Sutter, DE
Arne Sutter, Muehltal DE
| Patent application number | Description | Published |
|---|---|---|
| 20080199850 | Egfr Dependent Modulation of Chemokine Expression and Influence on Therapy and Diagnosis of Tumors and Side Effects Thereof - The invention relates to diagnosis and therapy of tumors utilizinging the epidermal growth factor (EGFR) by means of chemical inhibitors or monoclonal antibodies. The invention relates also to skin irritations, preferably skin rash, in conjunction and associated with the treatment of tumor cells that utilize EGF receptor with anti-cancer agents. The invention is also directed to methods of predicting the efficiency of a tumor therapy/tumor response in a patient based on the treatment with EGFR inhibitors, especially anti-EGFR antibodies. The invention further relates to a method of determining the optimum dose of an anti-cancer agent in EGFR related tumor therapy. | 08-21-2008 |
| 20110244506 | EGFR DEPENDENT MODULATION OF CHEMOKINE EXPRESSION AND INFLUENCE ON THERAPY AND DIAGNOSIS OF TUMORS AND SIDE EFFECTS THEREOF - The invention relates to diagnosis and therapy of tumors utilizing the epidermal growth factor (EGFR) by means of chemical inhibitors or monoclonal antibodies. The invention relates also to skin irritations, preferably skin rash, in conjunction and associated with the treatment of tumor cells that utilize EGF receptor with anti-cancer agents. The invention is also directed to methods of predicting the efficiency of a tumor therapy/tumor response in a patient based on the treatment with EGFR inhibitors, especially anti-EGFR antibodies. The invention further relates to a method of determining the optimum dose of an anti-cancer agent in EGFR related tumor therapy. | 10-06-2011 |
Bert Sutter, Freiburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20080262493 | BIPOLAR SCISSORS WITH CURVED SHEAR BLADES - Bipolar scissors ( | 10-23-2008 |
| 20090171352 | CUTTING AND COAGULATION ELECTRODE - In an electro-surgical instrument ( | 07-02-2009 |
| 20130338668 | COAGULATION FORCEPS WITH A TUBULAR SHAFT - A coagulation forceps with a tubular shaft and with two forceps limbs and, which can both be movable or of which one is fixed, are uncovered on the gripping surfaces that face one another and serve for gripping tissue to be treated. At the distal ends, they have end surfaces, which contact a common plane, and are insulated on their outer sides that face away from one another, and provision is made for current connections for connection to a radiofrequency generator or to a current source for bipolar coagulation. Here, not only the gripping surfaces, but also the distal end surfaces of the forceps limbs and are uncovered and these uncovered end surfaces can be connected to uncovered outer surfaces of the forceps limbs and continuing said end surfaces such that tissue contacted by the two end surfaces and/or the outer surfaces can also be coagulated in a bipolar manner. | 12-19-2013 |
Dirk Sutter, Rottweil DE
| Patent application number | Description | Published |
|---|---|---|
| 20120176666 | LASER APPARATUS AND METHOD TO GENERATE UV LASER LIGHT - This invention relates generally to laser systems that produce UV light and their methods of use. The phase matching of the conversion process has a broad temperature bandwidth so that precise temperature stabilization is not necessary to obtain a stable efficiency and a non-deformed laser beam with fast power modulation at high energies. | 07-12-2012 |
Gerd Sutter, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20100266630 | Recombinant MVA virus, and the use thereof - The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the site of a naturally occurring deletion in the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy, and the use of such recombinant MVA viruses encoding antigens as vaccines. | 10-21-2010 |
| 20100291139 | RECOMBINANT MVA VIRUS AND THE USE THEREOF - The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the site of a naturally occurring deletion in the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy, and the use of such recombinant MVA viruses encoding antigens as vaccines. | 11-18-2010 |
Gerd Sutter, Muenchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090191157 | USE OF RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) FOR THE TREATMENT OF TYPE 1 HYPERSENSITIVITY IN A LIVING ANIMAL INCLUDING HUMANS - The present invention relates to the use of a recombinant modified vaccinia virus Ankara (MVA) comprising a heterologous nucleic acid for the production of a medicament for the prevention and/or treatment of type I hypersensitivity in a living animal including humans. The invention further relates to a recombinant modified vaccinia virus Ankara (MVA) comprising a heterologous nucleic acid, wherein the heterologous nucleic acid is incorporated into a non-essential region of the genome of the MVA, the heterologous nucleic acid is under the control of, e.g. a vaccinia virus-specific promoter and, the heterologous nucleic acid is selected from the group of nucleic acids encoding an allergen selected from the group of weed pollens, grass pollens, tree pollens, mites, animals, fungi, insects, rubber, worms, human autoallergens, and foods. | 07-30-2009 |
Gerd Sutter, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090238843 | RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA. | 09-24-2009 |
| 20110020391 | RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA)-BASED VACCINE FOR THE AVIAN FLU - The present invention relates to the use of a recombinant modified vaccinia virus Ankara (MVA) comprising a heterologous nucleic acid for the production of a medicament in particular a vaccine, wherein the sequence of heterologous nucleic acid is from influenza A virus class H5 antigen. In a further aspect of the invention the invention relates to a recombinant modified vaccinia virus Ankara (MVA) comprising a heterologous nucleic acid, wherein (a) the heterologous nucleic acid is incorporated into a non-essential site within the genome of MVA, (b) the heterologous nucleic acid is under the control of a vaccinia virus promoter, or orthopoxvirus promoter, or poxvirus-specific promoter and, (c) the heterologous nucleic acid is selected from the group of nucleic acids encoding a gene or a part of a gene from an influenza A virus class H5. | 01-27-2011 |
| 20110293656 | RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA. | 12-01-2011 |
| 20130089569 | RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA. | 04-11-2013 |
Hermann Sutter, Gundelfingen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100331837 | BIPOLAR COAGULATION FORCEPS - A bipolar coagulation forceps with a fixed forceps leg, a pivot support, and a pivoting forceps leg, which can pivot relative to the fixed forceps leg via a pivot element and which is electrically insulated from the fixed forceps leg is provided, with the forceps legs essentially being made from biocompatible metal. The pivot element is likewise essentially made from biocompatible metal and attaches directly to the moving forceps leg. An insulating body electrically insulating the pivot element and the moving forceps leg from the fixed forceps leg is arranged on or fixed to the fixed forceps leg as a pivot support, on which the moving forceps leg is supported by the pivot element. | 12-30-2010 |
Kai Sutter, Stuttgart DE
| Patent application number | Description | Published |
|---|---|---|
| 20090045267 | Method of operating a fuel injector - A method for operating an injection valve, in particular a fuel injector of an internal combustion engine, in which a trigger voltage is able to be applied to an actuator, designed as piezoelectric element, of the fuel injector in order to induce an injection of fluid, in particular fuel, supplied to the fuel injector via a supply system. A specifiable test voltage is applied to the actuator in a test triggering, and a fluid pressure prevailing in the supply system is detected at least during the test triggering in order to derive information about an operating state of the fuel injector and/or the actuator from the test voltage and the detected fluid pressure. | 02-19-2009 |
Manuel Sutter, Muenchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20120063928 | Pump Having a Filter Arrangement - A pump for pumping a medium from a suction side to a pressure side includes a filter arrangement. The filter arrangement includes an inflow path, a first outflow path, and a second outflow path. A hydrophobic membrane filter is arranged between the inflow path and the first outflow path. A hydrophilic membrane filter is arranged between the inflow path and the second outflow path. At least one section of the hydrophobic membrane filter and one section of the hydrophilic membrane filter are located opposite each other at a distance of no more than 1 mm so that a gas bubble that moves along with a medium flowing in the inflow path comes into contact with the hydrophobic membrane filter during the movement. The first and second outflow paths of the filter arrangement are connected to the suction side of the pump. | 03-15-2012 |
Mike Sutter, Maulburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20140089501 | Method for Locating a Field Device in an Automated Plant - A method for locating at least one field device in an automated plant, wherein the field device is connected via a network composed of a plurality of distributed field devices, and wherein a mobile terminal is applied for locating the field device. | 03-27-2014 |
Ralf Sutter, Weinheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20100216088 | LASER HANDPIECE, EXCHANGEABLE FIBER-OPTIC INSERT AND CONTROL UNIT THEREFOR - The invention relates to a laser handpiece | 08-26-2010 |
| 20150064648 | DENTAL HANDPIECE HAVING A ROLLING BEARING - A dental handpiece ( | 03-05-2015 |
Siegfried Sutter, Boeblingen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100042823 | Method, Apparatus, and Product for Providing a Scalable Trusted Platform Module in a Hypervisor Environment - A method, apparatus, and computer program product are described for implementing a trusted computing environment within a data processing system where the data processing system includes a single hardware trusted platform module (TPM). Multiple logical partitions are provided in the data processing system. A unique context is generated for each one of the logical partitions. When one of the logical partitions requires access to the hardware TPM, that partition's context is required to be stored in the hardware TPM. The hardware TPM includes a finite number of storage locations, called context slots, for storing contexts. Each context slot can store one partition's context. Each one of the partitions is associated with one of the limited number of context storage slots in the hardware TPM. At least one of the context slots is simultaneously associated with more than one of the logical partitions. Contexts are swapped into and out of the hardware TPM during runtime of the data processing system so that when ones of the partitions require access to the hardware TPM, their required contexts are currently stored in the hardware TPM. | 02-18-2010 |
Sven Martin Sutter, Herzogenaurach DE
| Patent application number | Description | Published |
|---|---|---|
| 20090028296 | X-RAY SYSTEM AND METHOD FOR COMPOSITION OF X-RAY IMAGES - In an imaging acquisition system and method, successive x-ray images and successive optical images are respectively acquired from an examination subject. Positional identifiers associated with the examination subject are detected in the optical images, and acquisition of respective x-ray images is triggered only when the identifiers are detected in the optical images. The number of acquired x-ray images is therefore substantially fewer than the number of acquired optical images, and the x-ray images can be acquired with substantially no overlap, thereby avoiding exposing the examination subject to unnecessary radiation. | 01-29-2009 |
Ulrike Sutter, Neuried DE
| Patent application number | Description | Published |
|---|---|---|
| 20100032089 | METHOD OF COATING WEB-FORM CARRIER MATERIALS WITH HIGH COATWEIGHT - Method of coating a web-form carrier material with an aqueously dispersed composition, the composition being applied to the carrier material with a suitable applicator with a coatweight of at least 10 g/m | 02-11-2010 |
Wolfgang Sutter, Halstenbek DE
| Patent application number | Description | Published |
|---|---|---|
| 20100149825 | Escape Path Marking for an Aircraft - Escape path marking for aircraft, which has an afterglowing photoluminescing material which is placed in several elements on the floor, characterised in that at least one element has a bent shape. | 06-17-2010 |
| 20100165647 | Escape Path Marking for an Aircraft - Escape path marking for an aircraft having a plurality of photoluminescent elements glow in the dark and of which each has a carrier element that is provided for attaching to a subsurface, characterised in that the carrier element has connecting edges on one or both end sides, the edges having an arc-shaped progression or having at least two sections not extending perpendicular to an orientation axis of the carrier element disposed perpendicularly on a cross section in the region of the connecting edge, the orientation axes of two carrier elements disposed successively enclosing an angle with each other. | 07-01-2010 |
| 20110049756 | Escape Route Marking for an Aircraft and Method for Producing an Escape Route Marking - Escape route marking for an aircraft comprising photoluminescent pigments in a carrier material, which luminesce in the dark, | 03-03-2011 |
| 20120091607 | Escape Route Marking for an Aircraft and Method for Producing an Escape Route Marking - Escape route marking for an aircraft comprising photoluminescent pigments in a carrier material, which luminesce in the dark, | 04-19-2012 |
| 20120282428 | Method for producing an escape route marking and an escape route marking - A method for producing an escape route marking and the apparatus for an airplane comprising a luminous layer that luminesces in the dark, and a profile having two profile elements that can be connected to each other, wherein in a first of the profile elements, the luminous layer is arranged in a recess extending in the longitudinal direction, and the second profile element is provided to be connected with a base, wherein the procedure comprises the following steps: | 11-08-2012 |